The Business Research Company published its Dermatology Drugs Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Dermatology Drugs market. The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.
The report covers the dermatology drugs
market’s segments-
1) By Type:
Acne, Dermatitis, Psoriasis, Other Drugs for Dermatology Diseases
2) By
Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores,
Others
3) By Route
Of Administration: Oral, Parenteral, Others
4) By Drug
Classification: Branded Drugs, Generic Drugs
5) By Mode
Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs.
View Complete Report:
Dermatology Drugs Global Market Report 2020 is the most
comprehensive report available on this market and will help gain a truly global
perspective as it covers 60 geographies. The chapter on the impact of COVID-19
gives valuable insights on supply chain disruptions, logistical challenges, and
other economic implications of the virus on the market. The chapter also covers
markets which have been positively affected by the pandemic.
The global dermatology drugs market is expected to decline
from $40.7 billion in 2019 to $36 billion in 2020 at a compound annual growth
rate (CAGR) of -11.7%. The decline is mainly because of drop in sales due to
the lockdown measures to contain COVID-19 spread. Apart from restricting
non-emergency medical services, new rules of the governments across the globe
has forced many companies in the dermatology drug market to halt their business
operations which has impacted the market growth. The market is then expected to
recover and grow at a CAGR of 13% from 2021 and reach $66.3 billion in 2023.
Pharmaceutical companies are offering new drugs referred to
as immune modulators for the treatment of skin diseases such as eczema. Eczema
is a chronic skin condition caused by the lack of skin proteins that results in
inflammation and irritation in the skin. These drugs are used to externally
treat the skin without changing the immune system of the body. In addition,
unlike topical steroids, these new medications do not cause thinning of the
skin and breaking of superficial blood vessels.
Few Points From Table Of Content
1. Executive
Summary
2. Report Structure
3. Dermatology Drugs Market Characteristics
4. Dermatology Drugs Market Product Analysis
5. Dermatology Drugs Market Supply Chain
……
20. Key Mergers And Acquisitions In The Dermatology Drugs Market
21. Market Background: Pharmaceutical Drugs Market
22. Recommendations
23. Appendix
24. Copyright And Disclaimer
Request A Sample Report At: https://www.thebusinessresearchcompany.com/sample.aspx?id=2135&type=smp
Few Points From List
Of Tables
Table 1: Historic Market Growth, Value ($ Billion)
Table 2: Forecast Market Growth, Value ($ Billion)
Table 3: Global Dermatology Drugs Market, 2019, By Region,
Value ($ Billion)
Table 4: Global Dermatology Drugs Market, 2015-2019, 2023F,
2025F, 2030F, Historic And Forecast, By Region
Table 5: Global Dermatology Drugs Market, Growth And Market
Share Comparison, By Region
………
Table 114: Global Pharmaceutical Drugs Market, 2015-2019,
2023F, 2025F, 2030F, Historic And Forecast, By Region
Table 115: Global Pharmaceutical Drugs Market, 2015-2019,
2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)
Table 116: Global Dermatology Drugs Market In 2023- Growth
Countries
Table 117: Global Dermatology Drugs Market In 2023- Growth
Segments
Table 118: Global Dermatology Drugs Market In 2023- Growth
Strategies
About The Business
Research Company:
The Business
Research Company is a Business Intelligence Company which excels in company,
market and consumer research. It has offices in the UK, the US and India and a
network of trained researchers in 52 countries globally.
Contact Information:
The Business Research
Company
Europe: +44 207 1930
708
Asia: +91 8897263534
Americas: +1 315 623
0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
No comments:
Post a Comment